Observational studyRMD open2026

Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry.

Koshiro Sonomoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.